AbstractObjectivesThe purpose of this study is to determine the clinical features of post-acute COVID-19 syndrome and the effectiveness and safety of Korean medicine treatment at the Public health center.
MethodsThe study was conducted among 11 patients with post-acute COVID-19 syndrome who attended a single public health center from January to December 2022. We retrospectively analyzed the charts of 11 patients and collected clinical characteristics, previous treatments, Korean medicine treatments, outcome variables (Numeral Rating Scale (NRS), Leicester Cough Questionnaire (LCQ), Visual Analog Scale (VAS)), adverse events, etc.
ResultsOf the 11 patients, six were women, and the average age of all patients was 68.27±12.31 years. The most common symptom were cough(n=9, 81.82%) and sore throat(n=9, 81.82%), followed by sputum, fatigue, rhinorrhea, and loss of appetite, etc. All 11 patients were treated with herbal medicine, with Samso-eum(n=6, 54.55%), Yeonkyopaedok-san(n=5, 45.45%), and Haengso-tang(n=3, 27.27%) being the most commonly used. After herbal medicine treatment, the median cough NRS decreased from 5 to 1, and the median sore throat NRS decreased from 4 to 1, both of which were statistically significant. One patient reported adverse event of dyspepsia and heartburn, but it was mild.
참고문헌1. Central Disease Control Headquarters, Central Disaster Management Headquarters. (2022). The COVID-19 At-Home Treatment Guideline (Ver.7). Korea. Korea Disease Control and Prevention Agency.
2. Kim, Y, Kim, SE, Kim, T, Yun, KW, Lee, SH, & Lee, E, et al. (2022). Preliminary Guidelines for the Clinical Evaluation and Management of Long COVID. Infect Chemother, 54(3), 566-597. 10.3947/IC.2022.0141
3. Groff, D, Sun, A, Ssentongo, AE, Ba, DM, Parsons, N, & Poudel, GR, et al. (2021). Short-term and Long-term Rates of Postacute Sequelae of SARS-CoV-2 Infection: A Systematic Review. JAMA Netw Open, 4(10), e2128568. 10.1001/JAMANETWORKOPEN.2021.28568
 4. Kim, Y, Bitna-Ha, , Kim, SW, Chang, HH, Kwon, KT, & Bae, S, et al. (2022). Post-acute COVID-19 syndrome in patients after 12 months from COVID-19 infection in Korea. BMC Infect Dis, 22(1), 93. 10.1186/S12879-022-07062-6
5. Kim, D, Jerng, UM, & Lee, JY. (2022). An Overview of Clinical Features, and Medical Access Among Patients with Post-Acute COVID-19 Syndromes: Analysis of a Nationwide Survey in Korea. Perspect Integr Med, 1(1), 21-33. 10.56986/PIM.2022.09.005
6. Kim, Y, Kim, SW, Chang, HH, Kwon, KT, Bae, S, & Hwang, S. (2021). Significance and Associated Factors of Long-Term Sequelae in Patients after Acute COVID-19 Infection in Korea. Infect Chemother, 53(3), 463-476. 10.3947/IC.2021.0022
7. Hale, N, Meit, M, Pettyjohn, S, Wahlquist, A, & Loos, M. (2022). The implications of long COVID for rural communities. J Rural Health, 38(4), 945-947. 10.1111/JRH.12655
8. Lee, JH. (2016). The Regional Health Inequity, and Individual and Neighborhood Level Health Determinants. Heal Soc Welf Rev, 36(2), 345-384. 10.15709/HSWR.2016.36.2.345
9. An S, Kim N, Kim Y. (2019). Comparison of Health Status and the Effectiveness of Health Cost between Rural and Urban Residents. Korea Rural Economic Institute.
10. Pang, W, Yang, F, Zhao, Y, Dai, E, Feng, J, & Huang, Y, et al. (2022). Qingjin Yiqi granules for post-COVID-19 condition: A randomized clinical trial. J Evid Based Med, 15(1), 30-38. 10.1111/JEBM.12465
11. An, X, Peng, B, Huang, X, Jiang, H, Xiong, Z, & Zhang, H, et al. (2022). Ludangshen oral liquid for treatment of convalescent COVID-19 patients: a randomized, double-blind, placebo-controlled multicenter trial. Chin Med, 17(1), 1-8. 10.1186/S13020-022-00602-X
12. Jang, S, Kim, D, Yi, E, Choi, G, Song, M, & Lee, EK. (2021). Telemedicine and the Use of Korean Medicine for Patients With COVID-19 in South Korea: Observational Study. JMIR Public Heal Surveill, 7(1), e20236. 10.2196/20236
13. Park, J, Hong, S, Shin, JW, Kim, KI, Lee, BJ, & Jung, HJ, et al. (2022). Effects of Korean Medicine Treatment in Post-acute COVID-19 Syndrome: A Retrospective Case Series of 15 Patients. J Intern Korean Med, 43(3), 396-412. 10.22246/JIKM.2022.43.3.396
14. Jeon, C, Choi, D, Kim, G, Kim, H, Leem, J, & Chi, GY, et al. (2022). Effect of Non-contact Korean Medical Treatment for Patients Recovering at Home with Positive Coronavirus Disease 2019 Diagnostic Test Results at a Local Public Health Center: A Retrospective Chart Review. J Physiol Pathol Korean Med, 36(4), 130-137. 10.15188/KJOPP.2022.08.36.4.130
15. Yu, CH. (2022). A Case Report of a Patient with Long COVID Complaining of Cough and Sore throat Treated with Hyunggaeyungyo-tang and Saengmaek-san. J Korean Med, 43(3), 204-210. 10.13048/JKM.22041
16. The jamovi project. 2022. jamovi (Version 2.3) [Computer Software]. Retrieved from https://www.jamovi.org
17. Long COVID or Post-COVID Conditions | CDC. Accessed February 20, 2023. Available from: https://www.cdc.gov/coronavirus/2019-ncov/long-term-effects/index.html
18. Su, Y, Yuan, D, Chen, DG, Ng, RH, Wang, K, & Choi, J, et al. (2022). Multiple early factors anticipate post-acute COVID-19 sequelae. Cell, 185(5), 881-895.e20. 10.1016/J.CELL.2022.01.014
19. Merzon, E, Weiss, M, Krone, B, Cohen, S, Ilani, G, & Vinker, S, et al. (2022). Clinical and Socio-Demographic Variables Associated with the Diagnosis of Long COVID Syndrome in Youth: A Population-Based Study. Int J Environ Res Public Health, 19(10), 10.3390/IJERPH19105993
20. Tenforde, MW, Kim, SS, Lindsell, CJ, Billig Rose, E, Shapiro, NI, & Files, DC, et al. (2020). Symptom Duration and Risk Factors for Delayed Return to Usual Health Among Outpatients with COVID-19 in a Multistate Health Care Systems Network - United States, March–June 2020. MMWR Morb Mortal Wkly Rep, 69(30), 993-998. 10.15585/MMWR.MM6930E1
21. Jung, YH, Ha, EH, Choe, KW, Lee, S, Jo, DH, & Lee, WJ. (2022). Persistent Symptoms After Acute COVID-19 Infection in Omicron Era. J Korean Med Sci, 37(27), e213. 10.3346/JKMS.2022.37.E213
22. Saunders, C, Sperling, S, & Bendstrup, E. (2023). A new paradigm is needed to explain long COVID. Lancet Respir Med, 11(2), e12-e13. 10.1016/S2213-2600(22)00501-X
23. Jiang, W, Qi, J, Li, X, Chen, G, Zhou, D, & Xiao, W, et al. (2022). Post-infectious cough of different syndromes treated by traditional Chinese medicines: A review. Chinese Herb Med, 14(4), 494-510. 10.1016/J.CHMED.2022.09.002
24. Song, WJ, & Kim, SH. (2019). New Approach to Chronic Cough: An Introductory Guide Based on Recent Clinical Practice Guidelines. Korean J Med, 94(6), 471-484. 10.3904/KJM.2019.94.6.471
25. Vijayakumar, B, Boustani, K, Ogger, PP, Papadaki, A, Tonkin, J, & Orton, CM, et al. (2022). Immuno-proteomic profiling reveals aberrant immune cell regulation in the airways of individuals with ongoing post-COVID-19 respiratory disease. Immunity, 55(3), 542-556.e5. 10.1016/J.IMMUNI.2022.01.017
26. McMaster, SR, Wilson, JJ, Wang, H, & Kohlmeier, JE. (2015). Airway-Resident Memory CD8 T Cells Provide Antigen-Specific Protection against Respiratory Virus Challenge through Rapid IFN-γ Production. J Immunol, 195(1), 203-209. 10.4049/JIMMUNOL.1402975
27. Deng, Z, Zhou, W, Sun, J, Li, C, Zhong, B, & Lai, K. (2018). IFN-γ Enhances the Cough Reflex Sensitivity via Calcium Influx in Vagal Sensory Neurons. Am J Respir Crit Care Med, 198(7), 868-879. 10.1164/RCCM.201709-1813OC
28. Sun, J, Zhan, C, Deng, Z, Luo, W, Chen, Q, & Jiang, M, et al. (2022). Expression of interferon-γ and its effect on cough hypersensitivity in chronic refractory cough patients. Thorax, 77(6), 621-624. 10.1136/THORAXJNL-2021-218403
29. Phetsouphanh, C, Darley, DR, Wilson, DB, Howe, A, Munier, CML, & Patel, SK, et al. (2022). Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection. Nat Immunol, 23(2), 210-216. 10.1038/S41590-021-01113-X
30. Krishna, B, Lim, E, Mactavous, L, Jackson, S, Lyons, P, & Bradley, J, et al. (2022). Spontaneous, persistent T-cell dependent IFN-γ release in patients who progress to Long COVID. Prepr (Version 2) available Res Sq, Published online November 21, 2022. 10.21203/RS.3.RS-2034285/V2
31. Kim, YC, & Song, WJ. (2022). Neuro-Immune Interactions and IFN-γ in Post-Infectious Cough. Allergy Asthma Immunol Res, 14(6), 581-584. 10.4168/AAIR.2022.14.6.581
32. De Araujo-Souza, PS, Hanschke, SCH, & Viola, JPB. (2015). Epigenetic control of interferon-gamma expression in CD8 T cells. J Immunol Res, (2015). 849573. 10.1155/2015/849573
33. Kaech, SM, & Cui, W. (2012). Transcriptional control of effector and memory CD8+ T cell differentiation. Nat Rev Immunol, 12(11), 749-761. 10.1038/NRI3307
34. Szabo, SJ, Kim, ST, Costa, GL, Zhang, X, Fathman, CG, & Glimcher, LH. (2000). A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell, 100(6), 655-669. 10.1016/S0092-8674(00)80702-3
35. Drae, Yoon, Sin, Hong, Hin, Noh, Sra, Yi, Ihee, Lee, & Jhwan, Lew, et al. (2013). Observation of Inflammatory Marker Levels in Sprague-Dawley Rats with Youngyopaedoc-san-related Anti-atherogenic Effect. J Korean Med, 34(3), 86-95. 10.13048/jkm.13014
36. KIM, JB, Kang, H, Ahn, KS, Sang, SB, Sung-Hoon, K, & Seung-hoon, C, et al. (2009). Effect of Soyangin-Hyeongbangpaedok-san on Anti-CD3 Stimulated Mouse T Cells In Vivo and In Vitro. J Physiol Pathol Korean Med, 23(3), 554-561.
37. Kim, HJ, Han, HJ, Jang, JA, Park, EY, An, TH, & Seo, HS, et al. (2010). Clinic Study on Herb Medication for Patients Who have a Chronic Respiratory Disease from the Cold Sequelae. J Herb Formula Sci, 18(1), 181-189.
38. Ryu, NH, Park, S, Kang, H, Sang, SB, Sung-Hoon, K, & Seung-hoon, C, et al. (2008). Effect of Samsoeum on Cytokine Regulation of Mouse T cell. J Physiol Pathol Korean Med, 22(4), 856-862.
39. Tang, WF, Tsai, HP, Chang, YH, Chang, TY, Hsieh, CF, & Lin, CY, et al. (2021). Perilla (Perilla frutescens) leaf extract inhibits SARS-CoV-2 via direct virus inactivation. Biomed J, 44(3), 293-303. 10.1016/J.BJ.2021.01.005
40. Rhee, SH, Kang, MS, Choi, YK, Jun, CY, Park, CH, & Kim, DW. (2006). Comparative study of 202 herbs on interferon-gamma secretion. J Intern Korean Med, 27(2), 336-344.
41. Shin, YS, Liu, JN, Kim, JH, Nam, YH, Choi, GS, & Park, HS. (2014). The Impact of Asthma Control on Salivary Cortisol Level in Adult Asthmatics. Allergy Asthma Immunol Res, 6(5), 463-466. 10.4168/AAIR.2014.6.5.463
42. Wei, P, Li, Y, Wu, L, Wu, J, Wu, W, & Chen, S, et al. (2021). Serum cortisol levels and adrenal gland size in patients with chronic obstructive pulmonary disease. Am J Transl Res, 13(7), 8150-8157.
43. Landstra, AM, Postma, DS, Marike Boezen, H, & Van Aalderen, WMC. (2002). Role of serum cortisol levels in children with asthma. Am J Respir Crit Care Med, 165(5), 708-712. 10.1164/AJRCCM.165.5.2102115
44. Choi, SY, & Han, SW. (1990). Effects of PaiMo-San water extract on the plasma cortisol concentraction and arterial blood PCO2, PO2 in the rabbit. J Intern Korean Med, 11(1), 127-140.
45. Vink, NM, Boezen, HM, Postma, DS, & Rosmalen, JGM. (2013). Basal or stress-induced cortisol and asthma development: the TRAILS study. Eur Respir J, 41(4), 846-852. 10.1183/09031936.00021212
46. The whole country a college of Orental medicine. The joint textbook publish commission compilatioin. (2011). Herbology. 2nd ed. Yonglimsa.
47. Kang, WJ, & Seo, UK. (2008). Effects of Haengso-tang and Chwiyeon-tang on Expression of Respiratory Mucin Gene and Secretion of Airway Mucus. J Korean Med, 29(3), 76-87.
48. The Association of Korean Medicine. 2020. Recommendation for Korean Medicine Treatment for COVID-19. Available from: https://nikom.or.kr/nckm/module/practiceGuide/viewPDF.do?guide_idx=125
49. Lee, K, Jeong, S, Jeong, M, Choi, Y, Song, M, & Jang, I. (2021). Review on Herbal Medicine Treatment for Late Complications of COVID-19 Patients. J Intern Korean Med, 42(1), 53-66. 10.22246/JIKM.2021.42.1.53
50. Kim, D, Park, SH, Sung, WS, & Kim, EJ. (2022). Current Status of Korean Medicine Treatment for Post-acute COVID-19 Syndrome: A Survey of Korean Medicine Doctors. Perspect Integr Med, 1(1), 34-44. 10.56986/PIM.2022.09.006
|
|
|||||||||||||||||||||||||||||||
|
|||||
PDF Links
Full text via DOI
PubReader
Download Citation 
Print 
